Quoin Pharmaceuticals. Ltd Sponsored ADR
(NASDAQ: QNRX)

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

5.900 -

- (-%)
Range 5.900 - 5.900   (-%)
Open 5.900
Previous Close 5.900
Bid Price 5.790
Bid Volume 10
Ask Price 6.980
Ask Volume 1,000
Volume -
Value -
Remark -
Delayed prices. Updated at 13 Apr 2026 19:03.
Data powered by
View All Events


Top Contributors

JonWick38 avatar
11600
Followers 277
Posts 2511

Loading Chart...

Please login to view stock data and analysis